TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33901161

Group type: EXPERIMENTAL
Intervention: Blue-enriched white light
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional light
Number of subjects: 48
Study: 34855001

Group type: EXPERIMENTAL
Intervention: Abbreviated total spine MRI protocol (IRsag + T2ax)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard non-contrast MRI protocol
Number of subjects: 206
Study: 33095994

Group type: EXPERIMENTAL
Intervention: noninvasive high-frequency oscillatory ventilation (nHFOV)
Number of subjects: 30

Group type: COMPARATOR
Intervention: nasal continuous positive airway pressure (nCPAP)
Number of subjects: 30
Study: 32131518

Group type: EXPERIMENTAL
Intervention: 20 mM oleic acid (OA) mouth rinse
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control mouth rinse
Number of subjects: 31
Study: 35132545

Group type: EXPERIMENTAL
Intervention: Walking-focused, proactive coaching intervention (6 telephone coaching sessions over 8-14 weeks)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Walking-focused, proactive coaching intervention
Number of subjects: 380

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 380
Study: 33908343

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy for insomnia (ICBT-I)
Number of subjects: 136630

Group type: COMPARATOR
Intervention: Usual-care arm (in-person classes on insomnia)
Number of subjects: 136630
Study: 34863046

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Low-fat diet (LF)
Number of subjects: 183
Study: 34490711

Group type: EXPERIMENTAL
Intervention: Rhythmic eye movements during virtual reality exposure therapy (VRET)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group undergoing exposure without rhythmic eye movements
Number of subjects: 53
Study: 32037380

Group type: EXPERIMENTAL
Intervention: Diuretic
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Nitrate
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Lifestyle modification
Number of subjects: 57
Study: 34750450

Group type: EXPERIMENTAL
Intervention: Neutral bicarbonate ionized water (NBIW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 0
Study: 35437246

Group type: EXPERIMENTAL
Intervention: Multimodal exercise intervention (balance programmes and walking programme delivered by physiotherapists over 6 months)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Multimodal exercise intervention
Number of subjects: 396
Study: 33546755

Group type: EXPERIMENTAL
Intervention: CT-P17
Number of subjects: 648

Group type: COMPARATOR
Intervention: EU-adalimumab
Number of subjects: 648
Study: 32294883

Group type: EXPERIMENTAL
Intervention: Apple Polyphenol (AP) 300 mg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Apple Polyphenol (AP) 600 mg/day
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 35581106

Group type: EXPERIMENTAL
Intervention: Cardamom inhalation therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 33313814

Group type: COMPARATOR
Intervention: CHW intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: CHW + CCT intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Control
Number of subjects: 0
Study: 33225972

Group type: EXPERIMENTAL
Intervention: Assisted by two midwives during the second stage of labour
Number of subjects: 2946

Group type: COMPARATOR
Intervention: Assisted by one midwife during the second stage of labour
Number of subjects: 2946

Group type: EXPERIMENTAL
Intervention: Two midwives intervention
Number of subjects: 2946

Group type: EXPERIMENTAL
Intervention: Questionnaires sent at 1 month and 1 year post-birth
Number of subjects: 2946
Study: 35979852

Group type: EXPERIMENTAL
Intervention: Adolescents in all cultural categories (Marginalization, Integration, Separation, Assimilation)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Adolescents in Integration and Assimilation
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Adolescents in Integration
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Adolescents in Marginalization, Integration, and Assimilation
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Parents across all acculturation categories
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Participants (both parents and adolescents)
Number of subjects: 280
Study: 34288956

Group type: EXPERIMENTAL
Intervention: Substance use (smoking, drug use, alcohol consumption)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Risk factors for substance use
Number of subjects: 424
Study: 32859329

Group type: EXPERIMENTAL
Intervention: Synbiotic (Bacillus coagulans plus inulin)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 36451448

Group type: EXPERIMENTAL
Intervention: 3D printing technology + PBL method
Number of subjects: 269

Group type: COMPARATOR
Intervention: Traditional teaching methods
Number of subjects: 269
Study: 34102020

Group type: EXPERIMENTAL
Intervention: UC-MSCs (1×10^6 /kg body weight in 100ml saline)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (100ml 0.9% saline)
Number of subjects: 40
Study: 32428747

Group type: EXPERIMENTAL
Intervention: rTMS and risperidone plus family intervention (combined group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: rTMS and risperidone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: family intervention and risperidone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: risperidone alone (risperidone group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (risperidone only)
Number of subjects: 200
Study: 35132052

Group type: EXPERIMENTAL
Intervention: CT scan
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: PET scan
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy followed by LDLT
Number of subjects: 1010
Study: 35977248

Group type: EXPERIMENTAL
Intervention: EHR-integrated access to the Minnesota PDMP
Number of subjects: 309

Group type: COMPARATOR
Intervention: Usual access to PDMP via web portal
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: EHR-integrated PDMP tool
Number of subjects: 309

Group type: COMPARATOR
Intervention: Web-based and delegate queries
Number of subjects: 309
Study: 33580692

Group type: EXPERIMENTAL
Intervention: Lactononadecapeptide (LNDP) tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study: 35200335

Group type: EXPERIMENTAL
Intervention: Smartwatch-based sensor for sleep quantification
Number of subjects: 38

Group type: COMPARATOR
Intervention: Smartwatch-based sensor for sleep quantification with clonazepam
Number of subjects: 38
Study: 33390422

Group type: EXPERIMENTAL
Intervention: Mealtime fast-acting insulin aspart
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Post-meal fast-acting insulin aspart
Number of subjects: 245

Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 245
Study: 32575103

Group type: EXPERIMENTAL
Intervention: Clary sage aromatherapy
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 36129696

Group type: EXPERIMENTAL
Intervention: Complete revascularization (additional PCI of angiographically significant nonculprit lesions)
Number of subjects: 4041

Group type: COMPARATOR
Intervention: Culprit lesion-only PCI
Number of subjects: 4041
Study: 32898346

Group type: EXPERIMENTAL
Intervention: Reminder-Focused Positive Psychiatry (RFPP)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT)
Number of subjects: 11
Study: 32926418

Group type: EXPERIMENTAL
Intervention: 450 mg Valganciclovir (VGCV) daily
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 900 mg Valganciclovir (VGCV) daily
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sampling strategies of plasma concentrations at 0 and 2 hours and 0, 2, and 4 hours after VGCV administration
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Clearance of creatinine
Number of subjects: 70
Study: 32690032

Group type: EXPERIMENTAL
Intervention: Sequentially combined tDCS with MT (SEQ)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Concurrently combined tDCS with MT (CON)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham tDCS with MT (SHAM)
Number of subjects: 28
Study: 34391078

Group type: EXPERIMENTAL
Intervention: 12-min sub-maximal fitness test on a cycle ergometer
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Higher pre-exercise cravings
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Lower cardiorespiratory fitness
Number of subjects: 117
Study: 32521890

Group type: EXPERIMENTAL
Intervention: Sorafenib combined with TACE
Number of subjects: 118

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 118
Study: 34454788

Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine (RV) with routine EPI vaccines
Number of subjects: 142
Study: 32183265

Group type: EXPERIMENTAL
Intervention: Grafting material applied during sinus floor elevation (test group)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No graft applied during sinus floor elevation (control group)
Number of subjects: 49
Study: 36448844

Group type: EXPERIMENTAL
Intervention: Telephone-delivered intervention for alcohol use problems
Number of subjects: 344
Study: 32686552

Group type: EXPERIMENTAL
Intervention: Biogenetic lecture
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control lecture
Number of subjects: 280
Study: 33207993

Group type: EXPERIMENTAL
Intervention: Partial Enteral Nutrition (PEN) - casein-based formula for 12 months providing 25% of estimated daily energy requirements
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Partial Enteral Nutrition (PEN)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-PEN (control group)
Number of subjects: 34
Study: 32215208

Group type: EXPERIMENTAL
Intervention: β-carotene supplementation
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Dietary vitamin C intake, fruit and vegetable intake
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Vitamin E supplementation
Number of subjects: 29133
Study: 35657656

Group type: EXPERIMENTAL
Intervention: CHOICE trial intervention (PC-based alcohol care management)
Number of subjects: 27
Study: 33196153

Group type: EXPERIMENTAL
Intervention: Subcutaneous evinacumab 450 mg weekly
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Subcutaneous evinacumab 300 mg weekly
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Subcutaneous evinacumab 300 mg every 2 weeks
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Intravenous evinacumab 15 mg/kg every 4 weeks
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Intravenous evinacumab 5 mg/kg every 4 weeks
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study: 33651448

Group type: EXPERIMENTAL
Intervention: rs671 GA/AA genotype
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Poor control of HDLC, LDLC, blood pressure, and HbA1c
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Drinking
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 2500
Study: 32883723

Group type: EXPERIMENTAL
Intervention: Online cognitive-behavioural therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 34981621

Group type: EXPERIMENTAL
Intervention: Biocon's Insulin‐R
Number of subjects: 42

Group type: COMPARATOR
Intervention: Humulin‐R
Number of subjects: 42
Study: 33861011

Group type: EXPERIMENTAL
Intervention: Commercial skin protection products
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 6
Study: 32826011

Group type: EXPERIMENTAL
Intervention: Lumbopelvic manipulation (LPM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham Lumbopelvic manipulation (positioning with no thrust)
Number of subjects: 44
Study: 32345092

Group type: EXPERIMENTAL
Intervention: Victimization-focused prevention tips (n = 114)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Perpetration-focused prevention tips (n = 103)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Study tips for control purposes (n = 104)
Number of subjects: 321
Study: 34376188

Group type: EXPERIMENTAL
Intervention: Home-based dialogical intervention
Number of subjects: 22
Study: 35190972

Group type: EXPERIMENTAL
Intervention: QLHER2 (test) at single doses escalating from 0.2 to 6 mg/kg
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: QLHER2
Number of subjects: 76

Group type: COMPARATOR
Intervention: Herceptin (reference) at 4 mg/kg
Number of subjects: 76
Study: 33137340

Group type: COMPARATOR
Intervention: EOS789 50 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EOS789 100 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: EOS789 100 mg plus 1600 mg sevelamer
Number of subjects: 20
Study: 32659641

Group type: EXPERIMENTAL
Intervention: Autologous rectus fascia pubovaginal sling surgery (Group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Synthetic transobturator vaginal tape procedure (Group II)
Number of subjects: 30
Study: 35793528

Group type: EXPERIMENTAL
Intervention: Tooth-borne (TB) rapid maxillary expander
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tooth bone-borne (TBB) rapid maxillary expander
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both TB and TBB groups
Number of subjects: 52
Study: 33648863

Group type: EXPERIMENTAL
Intervention: Self-management education intervention
Number of subjects: 117
Study: 36414488

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (meditation, cognitive training, exercise, and nutrition counseling)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 209
Study: 34075875

Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 9803

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 9803

Group type: EXPERIMENTAL
Intervention: Multifactorial falls prevention
Number of subjects: 9803
Study: 32561824

Group type: EXPERIMENTAL
Intervention: Exercise group (Ex, n=28)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (C, n=12)
Number of subjects: 40
Study: 33073599

Group type: EXPERIMENTAL
Intervention: Pre-lockdown (pre-LD) period
Number of subjects: 137

Group type: COMPARATOR
Intervention: During lockdown (LD) period
Number of subjects: 137

Group type: COMPARATOR
Intervention: Non-PVD related RRD
Number of subjects: 137

Group type: COMPARATOR
Intervention: PVR presence
Number of subjects: 137
Study: 33444455

Group type: EXPERIMENTAL
Intervention: Bag-Valve-Guedel Adaptor (BVGA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Face Mask
Number of subjects: 25
Study: 36145195

Group type: EXPERIMENTAL
Intervention: Choline intake in early pregnancy
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Food sources of choline
Number of subjects: 103
Study: 35221361

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block (TAP) for MH
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pectoral nerve block-II (PEC-II) for MRM
Number of subjects: 0
Study: 35565859

Group type: EXPERIMENTAL
Intervention: Amorphous Calcium Carbonate (ACC) supplementation (2000 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amorphous Calcium Carbonate (ACC)
Number of subjects: 30
Study: 33371744

Group type: EXPERIMENTAL
Intervention: High RID (Risk Information Detail) video messages about anorexia
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Low RID video messages about anorexia
Number of subjects: 419

Group type: COMPARATOR
Intervention: Control video about vaccination
Number of subjects: 419
Study: 32835498

Group type: EXPERIMENTAL
Intervention: 47 g/kg sunflower meal (SFM)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: 97 g/kg sunflower meal (SFM)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control diet (corn and soybean meal, 30 g/kg crude fibre)
Number of subjects: 480
Study: 34333146

Group type: EXPERIMENTAL
Intervention: Photodynamic Therapy (PDT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Trichloroacetic acid (TAA)
Number of subjects: 31
Study: 35426485

Group type: EXPERIMENTAL
Intervention: Newly developed biological therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional therapy with first- and second-line drugs
Number of subjects: 0
Study: 32758672

Group type: EXPERIMENTAL
Intervention: Role reversal after role-playing
Number of subjects: 36

Group type: COMPARATOR
Intervention: Role-playing twice
Number of subjects: 36
Study: 35410252

Group type: EXPERIMENTAL
Intervention: Intervention video promoting help-seeking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 0
Study: 33866222

Group type: EXPERIMENTAL
Intervention: Perceived descriptive norms and willingness to drink
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Alcohol prototype similarity and alcohol-related perceived vulnerability
Number of subjects: 1062
Study: 33184931

Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg for six weeks
Number of subjects: 4775

Group type: EXPERIMENTAL
Intervention: Atrasentan AUC increase
Number of subjects: 4775

Group type: EXPERIMENTAL
Intervention: Caucasian patients compared to Black patients
Number of subjects: 4775
Study: 34127610

Group type: EXPERIMENTAL
Intervention: Flywheel training (twice weekly squat and calf raise exercises for 6 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (time-matched control period)
Number of subjects: 19
Study: 32444540

Group type: EXPERIMENTAL
Intervention: Tolcapone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 36480811

Group type: EXPERIMENTAL
Intervention: zanubrutinib (80 mg BID) with moderate CYP3A inhibitors fluconazole and diltiazem
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: zanubrutinib (80 mg QD) with strong CYP3A inhibitor voriconazole
Number of subjects: 26

Group type: COMPARATOR
Intervention: zanubrutinib (320 mg QD)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: zanubrutinib
Number of subjects: 26
Study: 34020388

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (usual standard of care)
Number of subjects: 25
Study: 32745254

Group type: EXPERIMENTAL
Intervention: Machine learning model (random forest) for predicting progression-free survival (PFS)
Number of subjects: 104758

Group type: EXPERIMENTAL
Intervention: Machine learning model (random forest) for predicting overall survival (OS)
Number of subjects: 104758
Study: 34736768

Group type: EXPERIMENTAL
Intervention: YYD302
Number of subjects: 184

Group type: COMPARATOR
Intervention: Synovian
Number of subjects: 184
Study: 34275349

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 2000
Study: 33583887

Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG) training for 8 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control period (no IHG training)
Number of subjects: 53
Study: 33082194

Group type: EXPERIMENTAL
Intervention: Natalizumab 300 mg every 4 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Fingolimod 0.5 mg once daily
Number of subjects: 108
Study: 34983284

Group type: EXPERIMENTAL
Intervention: 3D printing group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional surgery group
Number of subjects: 40
Study: 33812035

Group type: EXPERIMENTAL
Intervention: Prophylactic CSFD
Number of subjects: 3406

Group type: COMPARATOR
Intervention: Therapeutic CSFD
Number of subjects: 3406
Study: 36977990

Group type: EXPERIMENTAL
Intervention: Linear-interaction model
Number of subjects: 4250

Group type: EXPERIMENTAL
Intervention: Restricted cubic splines model
Number of subjects: 4250

Group type: EXPERIMENTAL
Intervention: Adaptive approach using Akaike's Information Criterion
Number of subjects: 4250
Study: 33661781

Group type: EXPERIMENTAL
Intervention: Oral carbohydrate (group OC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral placebo (group OP)
Number of subjects: 120
Study: 32499503

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34050914

Group type: EXPERIMENTAL
Intervention: Early ultrasound performed by emergency physicians
Number of subjects: 103

Group type: COMPARATOR
Intervention: Routine assessment (control group)
Number of subjects: 103
Study: 34538458

Group type: EXPERIMENTAL
Intervention: General knowledge of IPV among respondents
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Intimate partner violence assessment relevance
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: History of IPV awareness training
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Estimation of IPV prevalence in practice
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Identification of active IPV victims
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Identification of IPV victims throughout careers
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Clinic guidelines for detection or management of IPV
Number of subjects: 95
Study: 35078853

Group type: EXPERIMENTAL
Intervention: 3-weekly durvalumab 1500 mg plus 3-weekly doublet chemotherapy (cisplatin 75 mg/m2 or carboplatin, AUC 5 and pemetrexed 500 mg/m2) for 4-6 cycles, followed by 4-weekly durvalumab 1500 mg until disease progression, unacceptable toxicity or patient withdrawal
Number of subjects: 480

Group type: COMPARATOR
Intervention: Doublet chemotherapy alone for 4-6 cycles, followed by observation
Number of subjects: 480
Study: 33238010

Group type: EXPERIMENTAL
Intervention: Digital rehabilitation program (application) along with traditional physical therapy (PT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional physical therapy (PT)
Number of subjects: 48
Study: 34779221

Group type: EXPERIMENTAL
Intervention: S‐ICD
Number of subjects: 849

Group type: COMPARATOR
Intervention: TV‐ICD
Number of subjects: 849
Study: 33271428

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: SGLT2 inhibitors (SGLT2i)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GLP1 receptor agonists (GLP1RA)
Number of subjects: 0
Study: 35149638

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy support (counseling, relaxation, mindfulness-based exercises)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard care and educational videos (Control)
Number of subjects: 90